Search

everythinglearnresearchcommunity

for

Search:↓

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Elaine Fuchs' research shows how skin stem cells maintain health, aid in healing, and are involved in cancer.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Non-invasive methods can effectively monitor skin inflammation and cancer biomarkers.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Frequent use of chemical hair relaxers may increase endometrial cancer risk in Black women.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Cancer survivors need better skin care to improve their quality of life.

Reporter characteristics affect detection of hair loss from cancer therapy.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Wnt-activating drugs generally do not increase cancer risk.

Certain blood markers can help predict and manage chemotherapy side effects in older cancer patients.

Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Men with baldness on the top of their head might have a small increased risk of prostate cancer.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Minoxidil may help with hair loss caused by cancer treatments.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

PCOS may increase the risk of certain cancers.